Cite
HARVARD Citation
Yada, K. et al. (2020). Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab. Arteriosclerosis, thrombosis, and vascular biology. 40 (5), p. . [Online].